People | 23 June 2022
Piramal Pharma Solutions appoints Herve Berdou as COO
Brings 25 years of global operations and supply chain experience to Piramal
Brings 25 years of global operations and supply chain experience to Piramal
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
New Director supports NASDAQ rule on diversity
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Company hires life science veteran Jessica Cao to join management team
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
AstraZeneca also played a critical role in the global response to COVID-19.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Subscribe To Our Newsletter & Stay Updated
